The biggest SHI fund, the AOK, proposes an end to free pricing in Germany
Currently, free pricing of products with a new chemical entity (NCE) applies in the first year. This means, at the time of
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Currently, free pricing of products with a new chemical entity (NCE) applies in the first year. This means, at the time of
You might be familiar with the price negotiations to derive the reimbursement price, but this does not always reflect the final, real-world
The process of determining the reimbursed price of a product with a new chemical entity is clearly defined and follows specific steps.
At the time of launch in the German market, pharmaceutical companies are free to set the price for their product with a
If the G-BA concludes its early benefit assessment with “No additional benefit (proven)” and the product falls into a reference price group,